Financhill
Back

KalVista Pharmaceuticals Quote, Financials, Valuation and Earnings

Buy
56

KALV
KalVista Pharmaceuticals

Last Price:
11.91
Seasonality Move:
3.19%

7 Day Trial

ALL ACCESS PASS

$ 7

KalVista Pharmaceuticals Price Quote

$11.91
-0.01 (-1.33%)
(Updated: May 18, 2024 at 5:47 AM ET)

KalVista Pharmaceuticals Key Stats

Buy
56
KalVista Pharmaceuticals (KALV) is a Buy

Day range:
$11.70 - $12.16
52-week range:
$7.21 - $16.88
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
32.37
P/B ratio:
5.68%

Volume:
337.6K
Avg. volume:
309.1K
1-year change:
15.84%
Market cap:
$502.9M
Revenue:
$0
EPS:
$-3.15

How Much Does KalVista Pharmaceuticals Make?

Data Unavailable

Is KalVista Pharmaceuticals Growing As A Company?

Data Unavailable

KalVista Pharmaceuticals Stock Price Performance

What Is KalVista Pharmaceuticals 52-Week High & Low?

KalVista Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy KalVista Pharmaceuticals?

Is KalVista Pharmaceuticals Cash Flow Positive?

  • What Is KALV Cash Flow From Operations?
    Cash flow from operations (TTM) is -$96.8M
  • What Is KalVista Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $583K
  • What Is KalVista Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $35.3M

KalVista Pharmaceuticals Return On Invested Capital

Data Unavailable

KalVista Pharmaceuticals Earnings Date & Stock Price

KalVista Pharmaceuticals Competitors

KalVista Pharmaceuticals Dividend Yield

Data Unavailable

KalVista Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -6.55%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 4
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 29.80
Upside from Last Price: 150%

Major Shareholders

  • How many KALV shares are owned by institutional investors?
    40.5M KALV shares are owned by institutional investors
  • How many KALV shares are owned by insiders?
    596.5K KALV shares are owned by insiders